• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 4 of 100
A man leans over and reaches for a bottle while standing in front of a shelf on medications.
EconomyTariffs threaten a pharmaceuticals shortage, as 95% of ibuprofen comes from China
By Sasha RogelbergApril 30, 2025
People walking by Viagra Connect ad seen in The Boots Pharmacy window in Dublin during Level 5 Covid-19 lockdown. On Thursday, 28 January, 2021, in Dublin, Ireland.
PoliticsViagra and Mounjaro panic-buying could be behind a 200% export surge from Ireland to the U.S.
By Ryan HoggApril 30, 2025
AstraZeneca CEO hopes U.S. will represent half of company’s global revenue by 2030—vows to invest and expand in nation despite tariff threat
FinanceAstraZeneca CEO hopes U.S. will represent half of company’s global revenue by 2030—vows to invest and expand in nation despite tariff threat
By AFPApril 29, 2025
Pharma giant Merck expects Trump’s tariffs to cost the company $200 million
HealthPharma giant Merck expects Trump’s tariffs to cost the company $200 million
By Maia Anderson and Healthcare BrewApril 25, 2025
A man walks next to a sign for the Roche Holding AG headquarters on April 11, 2025 in Basel, Switzerland. Before US President Donald Trump postponed a range of imminent tariffs, Switzerland was facing a daunting 31% levy on most Swiss goods to imported to the United States, a higher rate than would have been imposed on European Union countries. Such a tariff would've been high damaging to iconic Swiss industries like chocolate and watchmaking. The reprieve will provide breathing room for Swiss officials looking to negotiate a deal with the US, although Swiss goods will still face a 10% tariff in the meantime, and the fate of a potential separate tariff on pharmaceuticals is unknown.
HealthSwiss drugmaker Roche leans into Trump tariff formula with $50 billion promise to invest in U.S.
By Ryan HoggApril 22, 2025
Novo Nordisk slides on pressure from Lilly’s pill study
RetailNovo Nordisk slides on pressure from Lilly’s pill study
By Marthe Fourcade and BloombergApril 22, 2025
Trump eyes new tariffs on semiconductors and pharmaceuticals as U.S. only makes 20% of world’s drugs and 0% of advanced logic chips
PoliticsTrump eyes new tariffs on semiconductors and pharmaceuticals as U.S. only makes 20% of world’s drugs and 0% of advanced logic chips
By Elaine Kurtenbach and The Associated PressApril 15, 2025
LArs Freurgaard Jorgensen and Ursula von der Leyen pictured among Danish business leaders in 2024.
HealthEurope’s pharma titans confront von der Leyen with threat to yank $113 billion from EU and relocate to U.S. as Trump plans ‘major’ tariffs
By Ryan HoggApril 9, 2025
The Ha'penny Bridge is a pedestrian bridge built in 1816 over the River Liffey in Dublin, Ireland.
FinanceCould Trump tariffs solve Ireland’s housing crisis?
By Ryan HoggApril 8, 2025
Stock market numbers are displayed on the floor of the New York Stock Exchange during morning trading on April 03, 2025 in New York City. (Photo: Michael M. Santiago/Getty Images)
NewslettersHow Trump’s import tariffs shocked tech stocks
By Andrew NuscaApril 4, 2025
Siemens to boost drug discoveries using AI through the $5.1 billion acquisition of U.S. software firm Dotmatics
RetailSiemens to boost drug discoveries using AI through the $5.1 billion acquisition of U.S. software firm Dotmatics
By AFPApril 3, 2025
Recursion’s automated high throughput wet lab
FeaturesWill AI ever cure cancer? The multibillion-dollar race to bring the first AI-discovered drug to market
By Erika FryApril 3, 2025
Emma Walmsley, chief executive officer of GSK Plc, following a Bloomberg Television interview in London, UK, on Tuesday, July 16, 2024. The threat of superbugs is not sufficiently understood, Walmsley said.
LeadershipGSK employees perform anonymous ‘180’ surveys on their bosses, and CEO Emma Walmsley isn’t exempt
By Ryan HoggApril 2, 2025
Photo of Mark Cuban
HealthMark Cuban warns Trump’s tariffs mean his Cost Plus Drugs ‘won’t have a choice’ but to raise prices for consumers
By Ani FreedmanApril 1, 2025
Katherine Stueland
TechAs a kid, she raised money to cure cystic fibrosis. Now she’s the CEO of a $2.6 billion genetic testing company
By Andrew NuscaMarch 31, 2025
1
  • 2
  • 3
  • 4
  • 5
  • 6
...100
Most Popular
Economy
The U.S. government is spending $88 billion a month in interest on national debt—equal to spending on defense and education combinedplaceholder alt text
By Fortune EditorsApril 9, 2026
Success
Gen Z doesn't want your full-time job. They want several part-time roles, and it's reshaping the entire workforceplaceholder alt text
By Fortune EditorsApril 9, 2026
Energy
2 years ago, Saudi Arabia quietly canceled the ‘petrodollar’ deal with America that wired the world economy for 50 years. Then war broke out in Iranplaceholder alt text
By Fortune EditorsApril 7, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.